1260403-55-1 Usage
Description
(2-(ChloroMethyl)-4-(dibenzylaMino)phenyl)Methanol hydrochloride, also known as T001, is a chemical compound characterized by its non-nucleoside reverse transcriptase inhibitor (NNRTI) properties. It is specifically designed to inhibit the activity of the enzyme reverse transcriptase, which plays a crucial role in the replication process of the human immunodeficiency virus (HIV). The ability of T001 to block this enzyme effectively prevents the virus from multiplying and spreading within the host's body, making it a significant component in the antiretroviral therapy arsenal for HIV/AIDS patients.
Uses
Used in Pharmaceutical Industry:
(2-(ChloroMethyl)-4-(dibenzylaMino)phenyl)Methanol hydrochloride is used as an antiretroviral agent for the treatment of HIV/AIDS. It functions by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV, thereby preventing the virus from multiplying and spreading within the body. This action is vital in managing the progression of the disease and improving the quality of life for HIV/AIDS patients.
Used in Antiviral Research:
(2-(ChloroMethyl)-4-(dibenzylaMino)phenyl)Methanol hydrochloride is also used as a research compound for exploring its potential in treating other viral infections. Studies are being conducted to assess its efficacy against hepatitis B and possibly other viral diseases, expanding its applications beyond HIV/AIDS treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1260403-55-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,4,0 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1260403-55:
(9*1)+(8*2)+(7*6)+(6*0)+(5*4)+(4*0)+(3*3)+(2*5)+(1*5)=111
111 % 10 = 1
So 1260403-55-1 is a valid CAS Registry Number.
1260403-55-1Relevant articles and documents
HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS
-
, (2020/06/05)
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein HET, R1, R2, R3, R4, R5, L, L1, X1, X2, X3 and q are as defined herein. The compounds are inhibitors of adrenomedullin receptor subtype 2 (AM2). Also disclosed are the compounds for use in the treatment of diseases modulated AM2, including proliferative diseases such as cancer; pharmaceutical compositions comprising the compounds; methods for preparing the compounds; and intermediates useful in the preparation of the compounds.
